MCID: THY054
MIFTS: 54

Thyrotoxic Periodic Paralysis

Categories: Rare diseases, Genetic diseases, Neuronal diseases

Aliases & Classifications for Thyrotoxic Periodic Paralysis

MalaCards integrated aliases for Thyrotoxic Periodic Paralysis:

Name: Thyrotoxic Periodic Paralysis 49 55 28 69
Thyrotoxic Hypokalemic Periodic Paralysis 55 36

Characteristics:

Orphanet epidemiological data:

55
thyrotoxic periodic paralysis
Inheritance: Multigenic/multifactorial,Not applicable; Age of onset: Adult; Age of death: normal life expectancy;

Classifications:

Orphanet: 55  
Rare neurological diseases


Summaries for Thyrotoxic Periodic Paralysis

NIH Rare Diseases : 49 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 79102Disease definitionThyrotoxic periodic paralysis (TPP) is a rare neurological disease characterized by recurrent episodes of paralysis and hypokalemia during a thyrotoxic state.EpidemiologyIt is most common in Asian males (with male-to-female ratios ranging from 17:1 to 70:1) during the third decade of life: the annual incidence in Chinese and Japanese thyrotoxicosis patients is estimated at around 1/50, whereas it is estimated at 1-2/1,000 among non-Asian thyrotoxicosis patients.Clinical descriptionTPP manifests as recurrent episodes of acute muscular weakness of the four extremities that vary in severity from paresis to complete paralysis. Recovery occurs within 2-72 hours. Attacks typically occur at night and may be preceded by muscle cramps, aches and stiffness. Ocular, bulbar and respiratory involvement has also been reported but is rare. Attacks are triggered by ingestion of a high carbohydrate load or strenuous physical activity followed by a period of rest. Episodes only occur when patients are thyrotoxic but symptoms and classical signs of hyperthyroidism are often absent at the time of the first attack. TPP can occur in association with any cause of hyperthyroidism, but is most commonly associated with Graves' disease.EtiologyThe pathogenesis remains unclear. Genetic predisposition is thought to play a role in the pathogenesis of TPP and single nucleotide polymorphisms (SNPs) of the CACNA1S (1q32) and GABRA3 (Xq28) genes have been associated with TPP susceptibility in some Asian populations. Hypokalemia is the consequence of an extra- to intracellular potassium shift due to an increase in Na/K-ATPase pump activity, either as a direct response to thyroid hormone or indirectly via adrenergic stimulation, insulin or exercise.Diagnostic methodsBiochemical studies are essential for diagnosis, with mild-to-severe thyrotoxicosis and hypokalemia during attacks being the major findings. Other anomalies may include hypophosphatemia and hypomagnesemia, without changes in acid-base balance. EMG reveals myopathic changes during attacks and muscle excitability anomalies after a prolonged exercise test. ECG anomalies are also noted. Thyrotoxicosis is the key finding for distinguishing TPP from other causes of hypokalemic periodic paralysis (HOP), such as familial HOP (FHOP; see this term), and from other hypokalemic disorders with a transcellular potassium shift, and excessive renal potassium wasting or gastrointestinal losses.Differential diagnosisThe differential diagnosis may also include Guillain-Barré syndrome, transverse myelitis (see these terms), spinal cord compression and hysteria, as well as muscle weakness and fatigue associated with hyperthyroidism in patients with thyrotoxic myopathy or myasthenia gravis (see this term).Genetic counselingTPP usually occurs sporadicallyManagement and treatmentManagement of TPP includes definitive control of hyperthyroidism, prevention of attacks with propranolol and avoidance of precipitating factors. Potassium administration during attacks may prevent cardiac arrhythmias and hasten the recovery from paralysis.PrognosisThe prognosis for patients is good and TPP resolves when euthyroid status is achieved.Visit the Orphanet disease page for more resources. Last updated: 3/25/2009

MalaCards based summary : Thyrotoxic Periodic Paralysis, also known as thyrotoxic hypokalemic periodic paralysis, is related to thyrotoxic periodic paralysis 1 and graves disease 1, and has symptoms including periodic hypokalemic paresis, episodic hypokalemia and hyperhidrosis. An important gene associated with Thyrotoxic Periodic Paralysis is KCNJ18 (Potassium Voltage-Gated Channel Subfamily J Member 18), and among its related pathways/superpathways are Cardiac conduction and Collagen chain trimerization. The drugs calcitonin and Immunoglobulins have been mentioned in the context of this disorder. Affiliated tissues include thyroid, testes and heart, and related phenotypes are behavior/neurological and muscle

Wikipedia : 72 Thyrotoxic periodic paralysis (TPP) is a condition featuring attacks of muscle weakness in the presence... more...

Related Diseases for Thyrotoxic Periodic Paralysis

Graphical network of the top 20 diseases related to Thyrotoxic Periodic Paralysis:



Diseases related to Thyrotoxic Periodic Paralysis

Symptoms & Phenotypes for Thyrotoxic Periodic Paralysis

Human phenotypes related to Thyrotoxic Periodic Paralysis:

55 31 (show all 42)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 periodic hypokalemic paresis 55 31 obligate (100%) Obligate (100%) HP:0008153
2 episodic hypokalemia 55 31 obligate (100%) Obligate (100%) HP:0012726
3 hyperhidrosis 55 31 hallmark (90%) Very frequent (99-80%) HP:0000975
4 obesity 55 31 hallmark (90%) Very frequent (99-80%) HP:0001513
5 palpitations 55 31 hallmark (90%) Very frequent (99-80%) HP:0001962
6 tetraplegia 55 31 hallmark (90%) Very frequent (99-80%) HP:0002445
7 hypomagnesemia 55 31 hallmark (90%) Very frequent (99-80%) HP:0002917
8 emg abnormality 55 31 hallmark (90%) Very frequent (99-80%) HP:0003457
9 episodic flaccid weakness 55 31 hallmark (90%) Very frequent (99-80%) HP:0003752
10 lower limb muscle weakness 55 31 hallmark (90%) Very frequent (99-80%) HP:0007340
11 mildly elevated creatine phosphokinase 55 31 hallmark (90%) Very frequent (99-80%) HP:0008180
12 transient hypophosphatemia 55 31 hallmark (90%) Very frequent (99-80%) HP:0008285
13 thyrotoxicosis with toxic multinodular goitre 55 31 hallmark (90%) Very frequent (99-80%) HP:0011785
14 thyrotoxicosis with toxic single thyroid nodule 55 31 hallmark (90%) Very frequent (99-80%) HP:0011786
15 increased intramyocellular lipid droplets 55 31 hallmark (90%) Very frequent (99-80%) HP:0012240
16 decreased urinary potassium 55 31 hallmark (90%) Very frequent (99-80%) HP:0012364
17 graves disease 55 31 hallmark (90%) Very frequent (99-80%) HP:0100647
18 urinary retention 55 31 frequent (33%) Frequent (79-30%) HP:0000016
19 hyporeflexia 55 31 frequent (33%) Frequent (79-30%) HP:0001265
20 tremor 55 31 frequent (33%) Frequent (79-30%) HP:0001337
21 weight loss 55 31 frequent (33%) Frequent (79-30%) HP:0001824
22 constipation 55 31 frequent (33%) Frequent (79-30%) HP:0002019
23 rhabdomyolysis 55 31 frequent (33%) Frequent (79-30%) HP:0003201
24 muscle cramps 55 31 frequent (33%) Frequent (79-30%) HP:0003394
25 muscle stiffness 55 31 frequent (33%) Frequent (79-30%) HP:0003552
26 exercise-induced muscle fatigue 55 31 frequent (33%) Frequent (79-30%) HP:0009020
27 postprandial hyperglycemia 55 31 frequent (33%) Frequent (79-30%) HP:0011998
28 prolonged qt interval 55 31 occasional (7.5%) Occasional (29-5%) HP:0001657
29 ventricular fibrillation 55 31 occasional (7.5%) Occasional (29-5%) HP:0001663
30 late-onset proximal muscle weakness 55 31 occasional (7.5%) Occasional (29-5%) HP:0003694
31 shortened pr interval 55 31 occasional (7.5%) Occasional (29-5%) HP:0005165
32 second degree atrioventricular block 55 31 occasional (7.5%) Occasional (29-5%) HP:0011706
33 ophthalmoparesis 55 31 very rare (1%) Very rare (<4-1%) HP:0000597
34 hyperkalemia 55 31 very rare (1%) Very rare (<4-1%) HP:0002153
35 respiratory paralysis 55 31 very rare (1%) Very rare (<4-1%) HP:0002203
36 hyperthyroidism 55 Obligate (100%)
37 paralysis 55 Very frequent (99-80%)
38 abnormality of muscle fibers 55 Very frequent (99-80%)
39 thyrotoxicosis with diffuse goiter 55 Very frequent (99-80%)
40 myotonia 55 Excluded (0%)
41 abnormality of peripheral nerve conduction 55 Excluded (0%)
42 impaired myocardial contractility 55 Excluded (0%)

MGI Mouse Phenotypes related to Thyrotoxic Periodic Paralysis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.56 ATP1A1 ATP1A2 ATP1B2 CACNA1S GABRA3 KCNJ2
2 muscle MP:0005369 9.1 ATP1A1 ATP1A2 ATP1B1 CACNA1S KCNJ2 ADRB2

Drugs & Therapeutics for Thyrotoxic Periodic Paralysis

Drugs for Thyrotoxic Periodic Paralysis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1 calcitonin
2 Immunoglobulins
3 Antibodies

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Genetic and Morphological Analysis of Thyrotoxic Periodic Paralysis Unknown status NCT02287363
2 Genetic Analysis of Thyrotoxic Periodic Paralysis Completed NCT00443833

Search NIH Clinical Center for Thyrotoxic Periodic Paralysis

Genetic Tests for Thyrotoxic Periodic Paralysis

Genetic tests related to Thyrotoxic Periodic Paralysis:

# Genetic test Affiliating Genes
1 Thyrotoxic Periodic Paralysis 28 CACNA1S

Anatomical Context for Thyrotoxic Periodic Paralysis

MalaCards organs/tissues related to Thyrotoxic Periodic Paralysis:

38
Thyroid, Testes, Heart, Spinal Cord, Skeletal Muscle, Pituitary, Colon

Publications for Thyrotoxic Periodic Paralysis

Articles related to Thyrotoxic Periodic Paralysis:

(show top 50) (show all 242)
# Title Authors Year
1
Novel lincRNA Susceptibility Gene and Its Role in Etiopathogenesis of Thyrotoxic Periodic Paralysis. ( 29264532 )
2017
2
Thyrotoxic periodic paralysis: A case report. ( 28293157 )
2017
3
Thyrotoxic periodic paralysis: an unusual presentation of hyperthyroidism. ( 29219824 )
2017
4
Paralysis that easily reverses: a case of thyrotoxic periodic paralysis. ( 28137907 )
2017
5
Thyrotoxic periodic paralysis as an initial presentation of Graves' disease in a Saudi patient. ( 28630226 )
2017
6
Down-regulation of Kir2.6 channel by c-termini mutation D252N and its association with the susceptibility to Thyrotoxic Periodic Paralysis. ( 28131627 )
2017
7
Thyrotoxic periodic paralysis: a case study and review of the literature. ( 28638574 )
2017
8
A rare cause of thyrotoxic periodic paralysis: liquorice consumption. ( 28258118 )
2017
9
Lower-Extremity Weakness in a Teenager Due to Thyrotoxic Periodic Paralysis. ( 27955984 )
2016
10
Whole genome and exome sequencing realignment supports the assignment of KCNJ12, KCNJ17, and KCNJ18 paralogous genes in thyrotoxic periodic paralysis locus: functional characterization of two polymorphic Kir2.6 isoforms. ( 27008341 )
2016
11
Is thyrotoxic periodic paralysis a disease caused by muscle membrane dysfunction? ( 28006864 )
2016
12
Thyrotoxic periodic paralysis. ( 27728745 )
2016
13
Steroid-induced thyrotoxic periodic paralysis during Graves' ophthalmopathy treatment. ( 27566533 )
2016
14
Thyrotoxic periodic paralysis: The immovable truth? A concise review of the literature. ( 27041083 )
2016
15
Thyrotoxic Periodic Paralysis and Polymorphisms of the ADRB2, AR, and GABRA3 Genes in Men with Graves Disease. ( 26676335 )
2016
16
Thyrotoxic periodic paralysis-A case report. ( 27728198 )
2016
17
Association of KCNJ2 Genetic Variants with Susceptibility to Thyrotoxic Periodic Paralysis in Patients with Graves' Disease. ( 28008586 )
2016
18
Thyrotoxic periodic paralysis- A case report. ( 27728174 )
2016
19
A Case of Nonfatal Ventricular Arrhythmia Due to Thyrotoxic Periodic Paralysis in a Saudi Patient as an Initial Presentation of Graves' Disease. ( 26843815 )
2016
20
Thyrotoxic Periodic Paralysis: A Puzzling Case of Chest Pain and Weakness. ( 26817428 )
2016
21
A case of thyrotoxic periodic paralysis with respiratory failure in an African American woman. ( 25934725 )
2015
22
Size of quadriceps femoris may contribute to thyrotoxic periodic paralysis. ( 26519100 )
2015
23
Thyrotoxic periodic paralysis in long standing graves' disease: an unusual presentation with normokalemia. ( 25839004 )
2015
24
Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition. ( 26623197 )
2015
25
Normokalemic thyrotoxic periodic paralysis with preserved reflexes- a unique case report. ( 25859483 )
2015
26
The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis. ( 25885757 )
2015
27
A rare case of thyrotoxic periodic paralysis precipitated by hydrocortisone. ( 25810683 )
2015
28
THYROTOXIC PERIODIC PARALYSIS, I^2-ADRENERGIC BRONCHODILATOR, AND INSULIN-AN INTERESTING INTERPLAY. ( 25227640 )
2014
29
Thyrotoxic periodic paralysis triggered by I^2-adrenergic bronchodilators. ( 24852589 )
2014
30
Thyrotoxic periodic paralysis: an endocrine cause of paraparesis. ( 24906287 )
2014
31
A case of thyrotoxic periodic paralysis as initial manifestation of Graves' disease in a 16-year-old Korean adolescent. ( 25346923 )
2014
32
Case of thyrotoxic periodic paralysis in a caucasian male and review of literature. ( 25484903 )
2014
33
Hypokalemia in thyrotoxic periodic paralysis: implication for nephrology practice. ( 24902491 )
2014
34
IN REPLY TO "THYROTOXIC PERIODIC PARALYSIS, I^2-ADRENERGIC BRONCHODILATOR, AND INSULIN-AN INTERESTING INTERPLAY". ( 25227641 )
2014
35
THYROTOXIC PERIODIC PARALYSIS, I^2-ADRENERGIC BRONCHODILATOR, AND INSULIN-AN INTERESTING INTERPLAY. ( 24742912 )
2014
36
Thyrotoxic periodic paralysis in a pediatric patient. ( 24378858 )
2014
37
Thyrotoxic periodic paralysis: clinical challenges. ( 24695373 )
2014
38
Evaluating the efficacy of primary treatment for graves' disease complicated by thyrotoxic periodic paralysis. ( 25147568 )
2014
39
IN REPLY TO "THYROTOXIC PERIODIC PARALYSIS, I^2-ADRENERGIC BRONCHODILATOR, AND INSULIN-AN INTERESTING INTERPLAY". ( 24742350 )
2014
40
Thyrotoxic periodic paralysis with Graves' disease leading to the discovery of a hidden nonclassic 11I^ hydroxylase deficiency. ( 23291679 )
2013
41
Thyrotoxic periodic paralysis: correct hypokalemia with caution. ( 23849367 )
2013
42
A rare case of thyrotoxic periodic paralysis with normokalemia. ( 23481615 )
2013
43
Thyrotoxic periodic paralysis presenting with ventricular storm. ( 22809769 )
2013
44
Episodes of paralysis in Chinese men with thyrotoxic periodic paralysis are associated with elevated serum testosterone. ( 23405854 )
2013
45
Thyrotoxic periodic paralysis triggered by I^2-adrenergic bronchodilators. ( 23816145 )
2013
46
Thyrotoxic periodic paralysis in Chinese patients: milder thyrotoxicosis yet lower dose of (131)I should be avoided. ( 23429401 )
2013
47
Thyrotoxic Periodic Paralysis: Diversity in America. ( 24315723 )
2013
48
Complete heart block during potassium therapy in thyrotoxic periodic paralysis. ( 22221982 )
2013
49
Thyrotoxic periodic paralysis: clinical and molecular aspects. ( 22918841 )
2013
50
The predisposition to thyrotoxic periodic paralysis (TPP) is due to a genetic variant in the inward-rectifying potassium channel, KCNJ2. ( 23803013 )
2013

Variations for Thyrotoxic Periodic Paralysis

ClinVar genetic disease variations for Thyrotoxic Periodic Paralysis:

6 (show all 12)
# Gene Variation Type Significance SNP ID Assembly Location
1 CACNA1S NM_000069.2(CACNA1S): c.-476G> A single nucleotide variant risk factor rs2281845 GRCh37 Chromosome 1, 201081943: 201081943
2 CACNA1S NM_000069.2(CACNA1S): c.258+57G> A single nucleotide variant risk factor rs1325310 GRCh37 Chromosome 1, 201079235: 201079235
3 CACNA1S NM_000069.2(CACNA1S): c.3414+67A> G single nucleotide variant risk factor rs28986463 GRCh38 Chromosome 1, 201060591: 201060591
4 KCNJ18 NM_001194958.2(KCNJ18): c.127C> T (p.Arg43Cys) single nucleotide variant Pathogenic rs527236151 GRCh38 Chromosome 17, 21702913: 21702913
5 KCNJ18 NM_001194958.2(KCNJ18): c.419C> T (p.Thr140Met) single nucleotide variant Pathogenic rs527236152 GRCh38 Chromosome 17, 21703205: 21703205
6 KCNJ18 NM_001194958.2(KCNJ18): c.502G> A (p.Val168Met) single nucleotide variant Pathogenic rs527236154 GRCh38 Chromosome 17, 21703288: 21703288
7 KCNJ18 NM_001194958.2(KCNJ18): c.598G> C (p.Ala200Pro) single nucleotide variant Pathogenic rs527236155 GRCh38 Chromosome 17, 21703384: 21703384
8 KCNJ18 NM_001194958.2(KCNJ18): c.1195C> T (p.Arg399Ter) single nucleotide variant Pathogenic rs527236156 GRCh38 Chromosome 17, 21703981: 21703981
9 KCNJ18 NM_001194958.2(KCNJ18): c.1219C> T (p.Gln407Ter) single nucleotide variant Pathogenic rs527236157 GRCh38 Chromosome 17, 21704005: 21704005
10 KCNJ18 NM_001194958.2(KCNJ18): c.429delC (p.Ile144Serfs) deletion Pathogenic,risk factor rs527236153 GRCh38 Chromosome 17, 21703215: 21703215
11 KCNJ18 NM_001194958.2(KCNJ18): c.1061C> T (p.Thr354Met) single nucleotide variant Pathogenic,risk factor rs527236158 GRCh38 Chromosome 17, 21703847: 21703847
12 KCNJ18 NM_001194958.2(KCNJ18): c.1097A> G (p.Lys366Arg) single nucleotide variant Pathogenic,risk factor rs527236159 GRCh38 Chromosome 17, 21703883: 21703883

Expression for Thyrotoxic Periodic Paralysis

Search GEO for disease gene expression data for Thyrotoxic Periodic Paralysis.

Pathways for Thyrotoxic Periodic Paralysis

Pathways related to Thyrotoxic Periodic Paralysis according to GeneCards Suite gene sharing:

(show all 26)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.75 ATP1A1 ATP1A2 ATP1B1 ATP1B2 CACNA1S KCNJ2
2
Show member pathways
12.7 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
3
Show member pathways
12.68 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
4
Show member pathways
12.56 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
5
Show member pathways
12.56 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
6
Show member pathways
12.45 ATP1A1 ATP1A2 ATP1B1 ATP1B2 GABRA3
7
Show member pathways
12.39 ADRB2 ATP1B1 ATP1B2 CACNA1S
8 12.15 CACNA1S KCNJ16 KCNJ2
9
Show member pathways
12.03 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4 CACNA1S
10 12 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
11
Show member pathways
11.91 GABRA3 KCNJ16 KCNJ2
12 11.9 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
13
Show member pathways
11.86 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
14 11.76 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
15 11.63 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4 CACNA1S
16 11.6 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
17 11.58 ADRB2 CACNA1S KCNJ2
18 11.55 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
19 11.5 ADRB2 ATP1A1 KCNJ2
20 11.47 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
21
Show member pathways
11.44 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
22 11.33 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
23 11.27 ADRB2 TSHR
24 11.15 ADRB2 TSHR
25 11.04 ATP1B1 ATP1B2
26 10.92 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4

GO Terms for Thyrotoxic Periodic Paralysis

Cellular components related to Thyrotoxic Periodic Paralysis according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 integral component of plasma membrane GO:0005887 9.98 ADRB2 ATP1B4 GABRA3 KCNJ16 KCNJ18 KCNJ2
2 apical plasma membrane GO:0016324 9.81 ADRB2 ATP1A1 ATP1B1 ATP1B2
3 basolateral plasma membrane GO:0016323 9.76 ATP1A1 ATP1B1 KCNJ16 TSHR
4 myelin sheath GO:0043209 9.7 ATP1A1 ATP1A2 ATP1B1
5 caveola GO:0005901 9.67 ATP1A1 ATP1A2 ATP1B1
6 extracellular vesicle GO:1903561 9.65 ATP1A1 ATP1A2 ATP1B1
7 sarcolemma GO:0042383 9.62 ATP1A1 ATP1A2 ATP1B1 CACNA1S
8 intercalated disc GO:0014704 9.46 ATP1A1 ATP1A2 ATP1B1 KCNJ2
9 T-tubule GO:0030315 9.26 ATP1A1 ATP1A2 CACNA1S KCNJ2
10 sodium:potassium-exchanging ATPase complex GO:0005890 9.02 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
11 membrane GO:0016020 10.18 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
12 plasma membrane GO:0005886 10.11 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 CACNA1S
13 integral component of membrane GO:0016021 10.03 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4

Biological processes related to Thyrotoxic Periodic Paralysis according to GeneCards Suite gene sharing:

(show all 35)
# Name GO ID Score Top Affiliating Genes
1 ion transmembrane transport GO:0034220 9.97 ATP1A1 ATP1A2 ATP1B1 ATP1B2 GABRA3
2 ion transport GO:0006811 9.96 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4 CACNA1S
3 sodium ion transport GO:0006814 9.91 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
4 regulation of ion transmembrane transport GO:0034765 9.89 CACNA1S KCNJ16 KCNJ18 KCNJ2
5 regulation of cardiac conduction GO:1903779 9.86 ATP1A1 ATP1A2 ATP1B1 ATP1B2
6 cellular response to mechanical stimulus GO:0071260 9.79 ATP1A1 ATP1A2 KCNJ2
7 cell communication by electrical coupling involved in cardiac conduction GO:0086064 9.78 ATP1A1 ATP1A2 ATP1B1 ATP1B2
8 cellular sodium ion homeostasis GO:0006883 9.76 ATP1A1 ATP1A2 ATP1B1 ATP1B2
9 regulation of cardiac muscle cell contraction GO:0086004 9.74 ATP1A1 ATP1A2 KCNJ2
10 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.73 ATP1A1 ATP1A2 ATP1B1 ATP1B2
11 membrane repolarization during cardiac muscle cell action potential GO:0086013 9.72 ATP1A1 ATP1B1 KCNJ2
12 potassium ion import across plasma membrane GO:1990573 9.71 ATP1A1 ATP1A2 ATP1B1
13 relaxation of cardiac muscle GO:0055119 9.71 ATP1A1 ATP1A2 ATP1B1 KCNJ2
14 ATP hydrolysis coupled transmembrane transport GO:0090662 9.7 ATP1A1 ATP1B1 ATP1B2
15 cardiac muscle contraction GO:0060048 9.67 ATP1A2 ATP1B1
16 membrane repolarization GO:0086009 9.67 ATP1A1 ATP1A2 ATP1B1 ATP1B2
17 ATP metabolic process GO:0046034 9.66 ATP1A2 ATP1B1
18 activation of adenylate cyclase activity GO:0007190 9.66 ADRB2 TSHR
19 positive regulation of ATPase activity GO:0032781 9.65 ATP1B1 ATP1B2
20 regulation of sodium ion transport GO:0002028 9.65 ADRB2 ATP1A1
21 regulation of the force of heart contraction GO:0002026 9.65 ATP1A1 ATP1A2
22 regulation of smooth muscle contraction GO:0006940 9.64 ADRB2 ATP1A2
23 cardiac muscle cell action potential involved in contraction GO:0086002 9.64 ATP1A1 KCNJ2
24 cellular response to steroid hormone stimulus GO:0071383 9.63 ATP1A1 ATP1A2
25 membrane depolarization during cardiac muscle cell action potential GO:0086012 9.63 ATP1A2 KCNJ2
26 negative regulation of heart contraction GO:0045822 9.62 ATP1A1 ATP1A2
27 sodium ion export across plasma membrane GO:0036376 9.62 ATP1A1 ATP1A2 ATP1B1 ATP1B2
28 positive regulation of potassium ion transmembrane transporter activity GO:1901018 9.61 ATP1B1 ATP1B2
29 response to glycoside GO:1903416 9.61 ATP1A1 ATP1A2
30 positive regulation of sodium ion export across plasma membrane GO:1903278 9.6 ATP1B1 ATP1B2
31 positive regulation of potassium ion import GO:1903288 9.58 ATP1B1 ATP1B2
32 potassium ion transport GO:0006813 9.56 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4 KCNJ16
33 cellular potassium ion homeostasis GO:0030007 9.55 ATP1A1 ATP1A2 ATP1B1 ATP1B2 KCNJ2
34 potassium ion import GO:0010107 9.17 ATP1A1 ATP1A2 ATP1B1 ATP1B2 KCNJ16 KCNJ18
35 transport GO:0006810 10.19 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4 CACNA1S

Molecular functions related to Thyrotoxic Periodic Paralysis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 voltage-gated ion channel activity GO:0005244 9.62 CACNA1S KCNJ16 KCNJ18 KCNJ2
2 ATPase activator activity GO:0001671 9.43 ATP1B1 ATP1B2
3 inward rectifier potassium channel activity GO:0005242 9.43 KCNJ16 KCNJ18 KCNJ2
4 G-protein activated inward rectifier potassium channel activity GO:0015467 9.4 KCNJ16 KCNJ2
5 steroid hormone binding GO:1990239 9.37 ATP1A1 ATP1A2
6 potassium ion binding GO:0030955 9.33 ATP1A1 ATP1A2 ATP1B1
7 sodium ion binding GO:0031402 9.13 ATP1A1 ATP1A2 ATP1B1
8 sodium:potassium-exchanging ATPase activity GO:0005391 8.92 ATP1A1 ATP1A2 ATP1B1 ATP1B2

Sources for Thyrotoxic Periodic Paralysis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....